Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports
08:04pm, Friday, 06'th Mar 2026
Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an end to a dispute between the two companies that escalated into a legal ba
YieldMax® HIMS Option Income Strategy ETF (HIYY) Trading Halt
03:19pm, Thursday, 05'th Mar 2026
MILWAUKEE, March 05, 2026 (GLOBE NEWSWIRE) -- Tidal Investments LLC (“Tidal”) announces that the YieldMax® HIMS Option Income Strategy ETF (NYSE Arca: HIYY) was halted to allow Tidal to evaluate
Hims and Hers Expands Its Technology Driven Consumer Health Platform
10:36am, Thursday, 05'th Mar 2026
HIMS expands its tech-driven care platform with data-led Labs testing, new menopause and testosterone services and global expansion into Canada.
Hims & Hers Slips as FDA Targets GLP-1 Compounders
12:18pm, Wednesday, 04'th Mar 2026
Hims and Hers Health (HIMS, Financials) traded lower after the U.S. Food and Drug Administration said it sent warning letters to telehealth companies it accused o
First Look: Target (TGT), Paramount (PSKY) and Gold in Focus
07:38am, Wednesday, 04'th Mar 2026
Stock News Wall Street whipsawed by Mideast turmoil: The SPDR S&P 500 ETF Trust (SPY) fell Tuesday, then futures steadied as oil volatility and safeâhaven flo
Hims & Hers Health: Leaving GLP-1s Behind
10:57am, Tuesday, 03'rd Mar 2026
Hims & Hers (HIMS) remains a 'Strong Buy' at $16, with fair value estimated at $22 despite recent headwinds. International expansion via the $1.15B Eucalyptus acquisition and product diversification a
Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports
10:40am, Tuesday, 03'rd Mar 2026
Hims & Hers Health's pharmacy partner, Strive Pharmacy, plans to resume sales of its compounded weight‑loss pill through other healthcare providers after halting distribution following U.S. re
Hims & Hers Health, Inc. (HIMS) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
08:17pm, Monday, 02'nd Mar 2026
Hims & Hers Health, Inc. (HIMS) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Carillon Eagle Small Cap Growth Fund Q4 2025 Portfolio Review
02:28pm, Monday, 02'nd Mar 2026
Coherent is expected to continue to benefit from a transition to products that enable faster throughput speeds, while prior constraints on manufacturing capacity appear to be alleviating. BrightSpring
Unexpected Stock Picks and Looking to the Future
12:35pm, Monday, 02'nd Mar 2026
In this podcast, Motley Fool contributors Rick Munarriz, Jason Hall, and Travis Hoium dive into stocks that they are willing to give up their Fool card for. There's also a look at how they think the p
Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
12:00pm, Monday, 02'nd Mar 2026
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it is investigating potential claims against the board of director
Hims expansion may not come in time for risky GLP-1 business
09:16am, Monday, 02'nd Mar 2026
Telehealth company Hims & Hers Health , known for its weight-loss drug business, is promising it can diversify away from its reliance on compounded GLP-1 sales in the U.S., but that may not happen soo
HIMS Core Business Faces Challenges in Guidance, GLP-1 Prices & NVO
04:00pm, Sunday, 01'st Mar 2026
Forward-looking guidance initially plagued Hims & Hers (HIMS) shares, says Christine Short, though she believes leadership did a good job at "refocusing" goals. She points to the company's businesses
Hims & Hers Health (NYSE:HIMS) & Strata Skin Sciences (NASDAQ:SSKN) Head-To-Head Analysis
04:48am, Sunday, 01'st Mar 2026
Strata Skin Sciences (NASDAQ: SSKN - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two busine
Hims & Hers Expands Digital Health and Global Platform Strategy
01:41pm, Friday, 27'th Feb 2026
HIMS expands into labs, cancer screening, menopause and global markets, advancing its digital, subscription-driven healthcare platform and preventive care.
